These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26233522)

  • 1. Coexpression of cyclin D1 and alpha-internexin in oligodendroglial tumors.
    Matsumura N; Nobusawa S; Ikota H; Hirato J; Hirose T; Yokoo H; Nakazato Y
    Brain Tumor Pathol; 2015 Oct; 32(4):261-7. PubMed ID: 26233522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-internexin and altered CIC expression as a supportive diagnostic marker for oligodendroglial tumors with the 1p/19q co-deletion.
    Nagaishi M; Suzuki A; Nobusawa S; Yokoo H; Nakazato Y
    Brain Tumor Pathol; 2014 Oct; 31(4):257-64. PubMed ID: 24197863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Internexin in the diagnosis of oligodendroglial tumors and association with 1p/19q status.
    Eigenbrod S; Roeber S; Thon N; Giese A; Krieger A; Grasbon-Frodl E; Egensperger R; Tonn JC; Kreth FW; Kretzschmar HA
    J Neuropathol Exp Neurol; 2011 Nov; 70(11):970-8. PubMed ID: 22002423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-Internexin expression identifies 1p19q codeleted gliomas.
    Ducray F; Crinière E; Idbaih A; Mokhtari K; Marie Y; Paris S; Navarro S; Laigle-Donadey F; Dehais C; Thillet J; Hoang-Xuan K; Delattre JY; Sanson M
    Neurology; 2009 Jan; 72(2):156-61. PubMed ID: 19139367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha internexin expression related with molecular characteristics in adult glioblastoma and oligodendroglioma.
    Suh JH; Park CK; Park SH
    J Korean Med Sci; 2013 Apr; 28(4):593-601. PubMed ID: 23579442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of chromosome 1p/19q in oligodendroglial tumors: refinement of chromosomal critical regions and evaluation of internexin immunostaining as a surrogate marker.
    Buckley PG; Alcock L; Heffernan J; Woods J; Brett F; Stallings RL; Farrell MA
    J Neuropathol Exp Neurol; 2011 Mar; 70(3):177-82. PubMed ID: 21293300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-internexin expression in gliomas: relationship with histological type and 1p, 19q, 10p and 10q status.
    Durand K; Guillaudeau A; Pommepuy I; Mesturoux L; Chaunavel A; Gadeaud E; Porcheron M; Moreau JJ; Labrousse F
    J Clin Pathol; 2011 Sep; 64(9):793-801. PubMed ID: 21653654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic value of alpha internexin expression in a series of 409 gliomas.
    Ducray F; Mokhtari K; Crinière E; Idbaih A; Marie Y; Dehais C; Paris S; Carpentier C; Dieme MJ; Adam C; Hoang-Xuan K; Duyckaerts C; Delattre JY; Sanson M
    Eur J Cancer; 2011 Mar; 47(5):802-8. PubMed ID: 21194923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
    Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T
    Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphous oligodendroglioma of Zülch revisited: a genetically heterogeneous group of anaplastic gliomas including tumors of bona fide oligodendroglial differentiation.
    Hewer E; Beck J; Murek M; Kappeler A; Vassella E; Vajtai I
    Neuropathology; 2014 Aug; 34(4):323-32. PubMed ID: 24444336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender.
    Gresner SM; Rieske P; Wozniak K; Piaskowski S; Jaskolski DJ; Skowronski W; Golanska E; Sikorska B; Liberski PP
    Clin Neuropathol; 2006; 25(1):18-24. PubMed ID: 16465770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granular cells in oligodendroglioma suggest a neoplastic change rather than a reactive phenomenon: case report with molecular characterisation.
    Rao S; Sravya P; Chandran C; Saini J; Somanna S; Santosh V
    Brain Tumor Pathol; 2017 Jan; 34(1):42-47. PubMed ID: 27738816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathology of oligodendroglial tumors.
    Hartmann C; von Deimling A
    Recent Results Cancer Res; 2009; 171():25-49. PubMed ID: 19322536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progenitor-like traits contribute to patient survival and prognosis in oligodendroglial tumors.
    Ng FS; Toh TB; Ting EH; Koh GR; Sandanaraj E; Phong M; Wong SS; Leong SH; Kon OL; Tucker-Kellogg G; Ng WH; Ng I; Tang C; Ang BT
    Clin Cancer Res; 2012 Aug; 18(15):4122-35. PubMed ID: 22675171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of non-glial intermediate filament proteins in gliomas.
    Hirato J; Nakazato Y; Ogawa A
    Clin Neuropathol; 1994; 13(1):1-11. PubMed ID: 7518371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OLIG2 as a specific marker of oligodendroglial tumour cells.
    Marie Y; Sanson M; Mokhtari K; Leuraud P; Kujas M; Delattre JY; Poirier J; Zalc B; Hoang-Xuan K
    Lancet; 2001 Jul; 358(9278):298-300. PubMed ID: 11498220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 expression in normal oligodendroglia and microglia cells: its use in the differential diagnosis of oligodendrogliomas.
    Bosone I; Cavalla P; Chiadò-Piat L; Vito ND; Schiffer D
    Neuropathology; 2001 Sep; 21(3):155-61. PubMed ID: 11666011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): a clinicopathologic study.
    Rodriguez FJ; Scheithauer BW; Jenkins R; Burger PC; Rudzinskiy P; Vlodavsky E; Schooley A; Landolfi J
    Am J Surg Pathol; 2007 Mar; 31(3):351-62. PubMed ID: 17325476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic signaling is dominant to cell of origin and dictates astrocytic or oligodendroglial tumor development from oligodendrocyte precursor cells.
    Lindberg N; Jiang Y; Xie Y; Bolouri H; Kastemar M; Olofsson T; Holland EC; Uhrbom L
    J Neurosci; 2014 Oct; 34(44):14644-51. PubMed ID: 25355217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.